NovaSterilis Inc - Company Review
NovaSterilis Inc - Company ReviewSummary
NovaSterilis Inc (NovaSterilis) is a supercritical carbon dioxide technology developer. The company's products include nova 2200 and nova 8800. Its nova is designed to incorporate supercritical carbon dioxide into sterilization process. NovaSterilis' products find applications in supercritical CO2, allograft tissue, biologic materials, additional applications and technical papers and data. The company utilizes SCCO2 terminal sterilization technology for developing its products. Its products are used for various applications in medical instruments, pharmaceuticals, biologics, vaccines, engineered tissues, devices and implants. NovaSterilis is headquartered in Lansing, New York, the US.
This comprehensive company report of NovaSterilis Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.